1276 studies found for:    multiple sclerosis.
Show Display Options
RSS Create an RSS feed from your search for:
multiple sclerosis.
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Not yet recruiting Phase 3, 28-week, Randomized, Double-blind, Placebo-controlled Safety and Efficacy Study of Nabiximols as an add-on Therapy in Subjects With Spasticity Due to Multiple Sclerosis.
Conditions: Spasticity;   Multiple Sclerosis
Interventions: Drug: Sativex;   Drug: Placebo
2 Withdrawn Immunoregulation by Controlled Parasite Exposure in Multiple Sclerosis.
Condition: Multiple Sclerosis
Interventions: Biological: Live Hookworm Larvae;   Other: Histamine
3 Withdrawn A Study of A4I Antagonist in Patients With Relapsing Multiple Sclerosis.
Condition: Multiple Sclerosis
Intervention: Drug: A4I Antagonist
4 Completed
Has Results
A Study of Sativex® for Relief of Spasticity in Subjects With Multiple Sclerosis.
Conditions: Spasticity;   Multiple Sclerosis
Interventions: Drug: Sativex®;   Drug: Placebo
5 Completed A Study to Evaluate the Safety and Effectiveness of Novantrone Therapy Followed by Copaxone for Multiple Sclerosis.
Condition: Relapsing Remitting Multiple Sclerosis
Interventions: Drug: glatiramer acetate 20 mg;   Drug: glatiramer acetate 20 mg, with mitoxantrone
6 Completed
Has Results
Duloxetine for Multiple Sclerosis Pain
Condition: Multiple Sclerosis
Interventions: Drug: Duloxetine Hydrochloride (HCI);   Drug: Placebo
7 Completed Effect of Tysabri in Patients With Relapsing-Remitting Multiple Sclerosis: A Follow-up Magnetization Transfer Imaging (MTI) Study
Condition: Multiple Sclerosis
Intervention: Drug: Tysabri
8 Unknown  The Neuroprotective Effect of Lamotrigine and Interferon Beta 1a in Patients With Relapsing-Remitting Multiple Sclerosis
Condition: Relapsing-Remitting Multiple Sclerosis
Intervention: Drug: lamotrigine
9 Recruiting Exploring the Efficacy and Safety of Siponimod in Patients With Secondary Progressive Multiple Sclerosis (EXPAND)
Condition: Secondary Progressive Multiple Sclerosis
Interventions: Drug: BAF312;   Drug: Placebo
10 Recruiting A Trial to Compare the Effectiveness of Two Rehabilitation Programs for Multiple Sclerosis Patients
Conditions: Primary Progressive Multiple Sclerosis,;   Secondary Progressive Multiple Sclerosis;   Relapsing-remitting Multiple Sclerosis,;   Demyelinating Autoimmune Diseases,;   Nervous System Diseases
Interventions: Behavioral: Combined program;   Behavioral: Physiotherapy in private practice
11 Terminated Motor Training and White Matter in Multiple Sclerosis (MS)
Condition: Multiple Sclerosis
Interventions: Device: tDCS;   Behavioral: Bimanual Training
12 Terminated
Has Results
Effect of Adrenocorticotropin Injection With Weekly Interferon Beta in Patients With Relapsing Remitting Multiple Sclerosis (MS)
Condition: Multiple Sclerosis
Interventions: Drug: repository corticotropin injection;   Drug: Saline
13 Recruiting Caprylic Triglyceride for Treatment of Cognitive Impairments in Multiple Sclerosis
Conditions: Relapsing Remitting MS;   Secondary Progressive MS;   Primary Progressive MS
Interventions: Dietary Supplement: Caprylic Triglyceride;   Dietary Supplement: Placebo
14 Completed Neurogenic Detrusor Overactivity Following Spinal Cord Injury or Multiple Sclerosis
Condition: Detrusor Muscle Hyperactivity
Interventions: Drug: Botulinum type A toxin (Dysport®);   Drug: Placebo
15 Unknown  Multiple Sclerosis Rehabilitation Study
Condition: Multiple Sclerosis
Interventions: Behavioral: Physiotherapy;   Behavioral: Occupational therapy;   Behavioral: Speech pathology
16 Completed
Has Results
A Study of the Long-term Safety of Sativex Use
Conditions: Multiple Sclerosis;   Spasticity;   Pain
Intervention: Drug: GW-1000-02
17 Terminated Multiple Doses of Anti-NOGO A in Relapsing Forms of Multiple Sclerosis
Condition: Multiple Sclerosis, Relapsing-Remitting
Interventions: Drug: GSK1223249;   Other: Saline placebo
18 Active, not recruiting A Prospective Pilot Study to Compare the Effectiveness of Prolonged Fasting and Low Glycemic Load Treatment in Respect to the Health Related Quality of Life in Multiple Sclerosis
Condition: Multiple Sclerosis
Intervention: Other: Comparison of prolonged fasting and low glycemic load treatment on health related quality of life in multiple sclerosis.
19 Recruiting The Efficacy of EMDR in Patients With PTSD in Multiple Sclerosis
Conditions: Posttraumatic Stress Disorders;   Multiple Sclerosis
Interventions: Behavioral: EMDR;   Behavioral: Relaxation
20 Completed
Has Results
Long-term Efficacy and Safety of Fingolimod (FTY720) in Patients With Relapsing-remitting Multiple Sclerosis
Condition: Multiple Sclerosis
Interventions: Drug: Fingolimod 0.5 mg;   Drug: Fingolimod 1.25 mg

Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results
Indicates status has not been verified in more than two years